pyridinolcarbamate has been researched along with 1-methyl-3-isobutylxanthine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bobkiewicz-Kozlowska, T; Forjasz-Grus, R | 1 |
1 other study(ies) available for pyridinolcarbamate and 1-methyl-3-isobutylxanthine
| Article | Year |
|---|---|
The xanthine derivatives and cerebral blood flow (CBF) after i.v. or i.c. administration in SHR rats.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Carotid Body; Cerebrovascular Circulation; Hypolipidemic Agents; Injections; Injections, Intravenous; Male; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Antagonists; Pyridinolcarbamate; Rats; Rats, Inbred SHR; Theophylline; Xanthines | 1996 |